Australian women will soon be able to bypass long GP waitlists and pick up the contraceptive pill and urinary tract infection (UTI) treatments straight from their local chemist under a major nationwide expansion.

In a major shake-up to healthcare access, Health Minister Mark Butler confirmed the Federal Government’s 12-month pilot program — originally limited to concession cardholders — will open to all eligible women from February 2027.

Obsessed with health news? Download our new app and never miss a headline

The move means around 900,000 Australian women are expected to benefit from free pharmacy consultations to treat uncomplicated UTIs, as well as access initial prescriptions or repeat supplies of hormonal contraception.

Perimenopause mythbusting

Under the updated rules, patient consultations with accredited community pharmacists will be completely free, funded directly by the Commonwealth.

General patients will pay no more than $25 per prescription, while concession cardholders will pay the standard capped fee of $7.70.

The trial — first announced in March 2026 as part of the government’s broader women’s health package — aims to relieve mounting pressure on overcrowded GP clinics while slashing out-of-pocket costs for everyday medical necessities.

Access to contraception without a doctor’s appointment will remain subject to state and territory regulations.

Several jurisdictions have already paved the way. NSW made pharmacy-led UTI treatment permanent in 2024, while Victoria allows trained pharmacists to assess and resupply certain hormonal contraceptives.

Community pharmacists have backed the announcement, saying the initiative gives women fast, accessible care when they need it most.

“Community pharmacy is Australia’s most accessible frontline healthcare destination and are open earlier, later and longer than other healthcare providers, making it easier to receive care and treatment,” Pharmacy Guild of Australia National President Professor Trent Twomey said.

The Albanese Government is pitching the pharmacy trial as a critical step toward eliminating cost barriers and wait times for essential women’s healthcare across the country.

The news spread across social media with many people, mainly women, applauding the government’s initiative.

“Great news for women, especially those living in remote areas/regional towns who don’t have access to bulk-billed practices and have to pay $120 for a standard two-minute GP consult for these everyday common scripts,” one user commented.

“This is incredible,” a second person wrote.

“About time,” a third wrote

“Huge day for me,” a fourth woman chimed in.